Lupin informs about transcript of conference call

25 May 2022 Evaluate

Pursuant to Regulation 30(2) read with Schedule Ill Part A Para A (15) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed a copy of the Transcript of the Q4 FY2022 Investor Meet/ Earnings Conference Call held on Thursday, May 19, 2022.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×